Form 8-K - Current report:
SEC Accession No. 0001437749-25-024487
Filing Date
2025-08-04
Accepted
2025-08-04 08:38:00
Documents
28
Period of Report
2025-08-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20250618d_8k.htm   iXBRL 8-K 28119
2 EXHIBIT 99.1 ex_832410.htm EX-99.1 92445
7 aacr_logo.jpg GRAPHIC 16362
8 ada_logo.jpg GRAPHIC 21484
9 asco_logo.jpg GRAPHIC 20415
10 asg_logo.jpg GRAPHIC 25227
11 cell.jpg GRAPHIC 46521
12 gen.jpg GRAPHIC 14703
13 genp.jpg GRAPHIC 4174
14 image1.jpg GRAPHIC 54286
15 image2.jpg GRAPHIC 65312
16 image3.jpg GRAPHIC 7103
17 image5.jpg GRAPHIC 7618
18 milestones.jpg GRAPHIC 84291
19 phase2.jpg GRAPHIC 29867
20 sig01.jpg GRAPHIC 4606
  Complete submission text file 0001437749-25-024487.txt   830277

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20250804.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20250804_def.xml EX-101.DEF 11807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20250804_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20250804_pre.xml EX-101.PRE 12022
30 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20250618d_8k_htm.xml XML 2933
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)